-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
UN warns 'intensified hostilities' ahead in Sudan despite RSF backing truce plan
-
Seven hospitalized after suspicious package opened at US base
-
Guardiola says 'numbers are insane' as he reaches 1,000 games in charge
-
Brazil welcomes China lift of ban on poultry imports
-
Scotland captain Tuipulotu bids for landmark win over All Blacks
-
Woman convicted in UK of harassing Maddie McCann's parents
-
Tanzania charges more than 100 with treason over election protests
-
Nexperia chip exports resuming: German auto supplier
-
Genge warns England to beware 'nasty' Fiji at Twickenham
-
Stocks fall on renewed AI bubble fears
-
UK grandmother on Indonesia death row arrives back in London
-
Spanish star Rosalia reaches for divine in new album
-
Portugal's Mendes out injured as Neves returns for World Cup qualifiers
-
Afghan-Pakistan peace talks push ahead after border clashes
-
Fleetwood in tie for lead at halfway stage in Abu Dhabi
-
Brazil court starts hearing Bolsonaro appeal
-
Serbia fast-tracks army HQ demolition for Trump family hotel
-
Ireland captain Doris 'mentally stronger' after long break
-
MSF accuses powerful nations of weakening S.Africa's G20 health text
-
Maresca defends Chelsea rotation policy after Rooney criticism
-
Hundreds of flights cut across US in government paralysis
-
Xhaka 'made me a better coach', says Arsenal boss Arteta
-
Central Nigerian town rebuilds religious trust in shadow of Trump's threat
-
Inside Germany's rare earth treasure chest
-
Former jihadist Syrian leader makes unprecedented White House visit
-
Kagiyama takes NHK lead in Japan to kick-start Olympic season
-
Ikea profits drop on lower prices, tariff costs
-
European, Asian stocks decline after Wall Street slide
-
Tuchel brings 'immense' Bellingham and Foden back into England fold
-
German FA extends with president Neuendorf until 2029
-
No end to Sudan fighting despite RSF paramilitaries backing truce plan
-
US officials, NGOs cry foul as Washington snubs UN rights review
-
Injured teen medal hope Tabanelli risks missing home Winter Olympics
-
Bellingham, Foden recalled to England squad for World Cup qualifiers
-
Tanzania rights group condemns 'reprisal killings' of civilians
-
Slot urges patience as Isak returns to training with Liverpool
-
Rees-Zammit set for Wales return with bench role against Argentina
-
China's new aircraft carrier enters service in key move to modernise fleet
-
Operation Cloudburst: Dutch train for 'water bomb' floods
-
Leaders turn up the heat on fossil fuels at Amazon climate summit
-
US travel woes mount as govt shutdown prompts flight cuts
-
North Korea fires unidentified ballistic missile: Seoul military
-
West Bank's ancient olive tree a 'symbol of Palestinian endurance'
-
Global tech tensions overshadow Web Summit's AI and robots
-
Green shines as Suns thump Clippers 115-102
-
Japan to screen #MeToo film months after Oscar nomination
-
Erasmus relishing 'brutal' France re-match on Paris return
-
Rejuvenated Vlahovic taking the reins for Juve ahead of Turin derby
-
'Well-oiled' Leipzig humming along in Bayern's slipstream
US Justice Dept takes abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The move by the administration of President Joe Biden came just hours after an appeals court blocked moves to ban mifepristone, but limited access to the drug used for more than half of the abortions in the United States.
"We will be seeking emergency relief from the Supreme Court... to protect Americans' access to safe and effective reproductive care," US Attorney General Merrick Garland said.
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone should remain available for now, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority federal appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the Food and Drug Administration's two-decades old approval of the drug last Friday.
The appeals court ruling was denounced by Planned Parenthood, the ACLU, the Center for Reproductive Rights and other groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
- 'Win' -
The anti-abortion group Susan B. Anthony described the latest ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, imposing a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
Th.Berger--AMWN